Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2

Prolyl hydroxylase (PHD) enzymes play a critical role in the cellular responses to hypoxia through their regulation of the hypoxia inducible factor α (HIF-α) transcription factors. PHD inhibitors show promise for the treatment of diseases including anaemia, cardiovascular disease and stroke. In this...

Descripció completa

Dades bibliogràfiques
Autors principals:	Richardson, NL, O'Malley, LJ, Weissberger, D, Tumber, A, Schofield, CJ, Griffith, R, Jones, NM, Hunter, L
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2021

Ítems similars

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
per: McNeill, L, et al.
Publicat: (2002)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
per: Hewitson, K, et al.
Publicat: (2007)

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
per: Appelhoff, R, et al.
Publicat: (2004)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
per: Chen, R, et al.
Publicat: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
per: Chen, R, et al.
Publicat: (2014)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
per: Astuti, D, et al.
Publicat: (2010)

Inhibition of a viral prolyl hydroxylase
per: Langley, G, et al.
Publicat: (2019)

Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
per: McDonough, M, et al.
Publicat: (2006)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
per: Holt-Martyn, J, et al.
Publicat: (2019)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
per: Maria Savyuk, et al.
Publicat: (2020-07-01)

Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition.
per: Trenton L Place, et al.
Publicat: (2013-01-01)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
per: Figg, WD, et al.
Publicat: (2021)

Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2
per: Figg, WD, et al.
Publicat: (2023)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
per: Chan, M, et al.
Publicat: (2016)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
per: Tian, Y, et al.
Publicat: (2006)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
per: Masson, N, et al.
Publicat: (2004)

The Prolyl Hydroxylase Domain 2 (PHD2) Deficiency Enhances Maximal Exercise Capacity
per: Junchul Shin
Publicat: (2024-02-01)

Prolyl hydroxylases and therapeutics.
per: Smith, T, et al.
Publicat: (2010)

Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from Dictyostelium discoideum and Toxoplasma gondii
per: Liu, T, et al.
Publicat: (2020)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
per: Astuti, D, et al.
Publicat: (2011)

Mechanism of molecular oxygen diffusion in a hypoxia-sensing prolyl hydroxylase using multiscale simulation
per: Domene, C, et al.
Publicat: (2020)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
per: Lippl, K, et al.
Publicat: (2015)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
per: Mecinovic, J, et al.
Publicat: (2007)

Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer.
per: Gossage, L, et al.
Publicat: (2010)

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.
per: Walmsley, SR, et al.
Publicat: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
per: Flashman, E, et al.
Publicat: (2010)

Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding
per: Thinnes, C, et al.
Publicat: (2018)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
per: Holt-Martyn, JP, et al.
Publicat: (2019)

Regulation of HIF: prolyl hydroxylases.
per: Stolze, I, et al.
Publicat: (2006)

Substrate selectivity of prolyl hydroxylases
per: McDonough, M
Publicat: (2018)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
per: Mole, D, et al.
Publicat: (2003)

Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury.
per: Schneider, M, et al.
Publicat: (2010)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice
per: Pan, J, et al.
Publicat: (2012)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice.
per: Pan, J, et al.
Publicat: (2012)

Hyperplasia of Pulmonary Neuroepithelial Bodies (NEB) in Lungs of Prolyl Hydroxylase-1(PHD-1) Deficient Mice
per: Pan, J, et al.
Publicat: (2012)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
per: Mecinović, J, et al.
Publicat: (2009)

Differential prolyl hydroxylation by six Physcomitrella prolyl-4 hydroxylases
per: Christine Rempfer, et al.
Publicat: (2024-12-01)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
per: Yeh, TL, et al.
Publicat: (2017)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
per: Schlemminger, I, et al.
Publicat: (2003)

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture
per: Bush, J, et al.
Publicat: (2018)